<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on July 28, 2020</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT03973580</url>
  </required_header>
  <id_info>
    <org_study_id>Western HSREB #113928</org_study_id>
    <nct_id>NCT03973580</nct_id>
  </id_info>
  <brief_title>Using Attention Training to Reduce Adolescents' Anxious Symptoms</brief_title>
  <acronym>ABM</acronym>
  <official_title>Altering High-risk Trajectories in Adolescent Anxiety Via Attention Bias Modification Training: Neural Predictors and Mechanisms (ABM Study)</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Western University, Canada</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>Western University, Canada</source>
  <oversight_info>
    <is_fda_regulated_drug>No</is_fda_regulated_drug>
    <is_fda_regulated_device>No</is_fda_regulated_device>
  </oversight_info>
  <brief_summary>
    <textblock>
      During adolescence, youth undergo rapid developmental change and in some cases experience
      increases in worries and fearfulness, although the mechanisms that underlie this change are
      unclear. Previous studies indicate that heightened Attentional Bias (AB) toward
      threat-related cues may increase fearfulness, and it may be possible to change AB using a
      computerized, Attention Bias Modification task (ABM). This study will recruit healthy youth
      with elevated anxious symptoms to index attentional tendencies toward threat-related stimuli
      using cutting-edge techniques, and to test the effect of a computerized attention training
      task in altering attention to threatening cues. The investigators will also examine the role
      of ABM in changing youth's attention-related resting-state functional connectivity (rsFC), a
      neural marker of at-rest cognition.
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      Adolescence is a critical period for increases in anxious symptoms, potentially due to
      etiologically significant Attention Biases (AB) favoring threatening cues. However, the
      specific facets of AB that drive this vulnerability as well as their neurocognitive
      correlates are unclear, due in large part to the poor psychometric properties of the
      traditional assessment of AB in this field. By using both a standard behavioral task and a
      novel eye-tracking task, this study aims to unpack the nuanced facets of AB related to
      anxiety risks. Additionally, well-controlled Attentional Bias Modification (ABM) tasks
      designed to train attention away from threatening cues can be used to experimentally
      manipulate the causal mechanisms of interest, and to test whether ABM reduces symptoms and
      alters patterns of resting-state functional connectivity (rsFC, the intrinsic brain activity
      that occurs outside specific tasks) that characterize anxiety risks.

      This study will recruit 60 11-13-year-old healthy adolescents with heightened anxious
      symptoms but without clinically significant anxiety disorders. They will be randomized to a
      six-session ABM training or a placebo task. Both before and after the training, the
      investigators will assess their anxious symptoms, AB, and rsFC. By examining the risk
      processes prior to the onset of clinically significant anxiety disorders, our work will make
      important new contributions to our understanding of how AB eventuates in anxiety and will
      have direct implications for early identification of youth at highest risk for anxiety
      disorders, and the targets that should be focused on in preventative efforts.
    </textblock>
  </detailed_description>
  <overall_status>Recruiting</overall_status>
  <start_date type="Actual">July 29, 2019</start_date>
  <completion_date type="Anticipated">December 2020</completion_date>
  <primary_completion_date type="Anticipated">August 2020</primary_completion_date>
  <phase>N/A</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Randomized</allocation>
    <intervention_model>Parallel Assignment</intervention_model>
    <intervention_model_description>Sixty adolescents will be randomly assigned to an active ABM task (n=30) or a control task (n=30) in parallel for the duration of the study.</intervention_model_description>
    <primary_purpose>Basic Science</primary_purpose>
    <masking>Double (Participant, Outcomes Assessor)</masking>
    <masking_description>The randomized assignment procedure will be conducted solely by the PI. All other research staff and participants will be blind to the assigned condition throughout the course of the study. The PI will use a random number generator in Excel to assign a number 1-10 for each participant. The number will be given to the study coordinator, who notes the number in the participant's file. Participants will be assessed by the coordinator or other research staff. The research staff goes to each participant's home to conduct the ABM training protocol, where the number noted in this participant's file will be entered at the start of the training task to assign the participant to either the ABM task or the control task. The PI will not run the tasks. In communicating with participants, the terms baseline, outcome, and training will not be used.</masking_description>
  </study_design_info>
  <primary_outcome>
    <measure>Change from baseline in parent-reported anxious symptoms at 3 weeks follow-up</measure>
    <time_frame>3 weeks from baseline (after completing the 3rd weekly training session)</time_frame>
    <description>Parent-reported anxious symptoms will be assessed by the Child Behavior Checklist questionnaire. The anxious syndrome subscale will be used with a score summed across the 12 items of this subscale. Scores for each item range from 0 to 2, and scores for the subscale range from 0 to 24. Higher scores indicate greater anxious symptoms.</description>
  </primary_outcome>
  <primary_outcome>
    <measure>Change from baseline in parent-reported anxious symptoms at 6 weeks follow-up</measure>
    <time_frame>6 weeks from baseline (after completing the 6th weekly training session)</time_frame>
    <description>Parent-reported anxious symptoms will be assessed by the Child Behavior Checklist questionnaire. The anxious syndrome subscale will be used with a score summed across the 12 items of this subscale. Scores for each item range from 0 to 2, and scores for the subscale range from 0 to 24. Higher scores indicate greater anxious symptoms.</description>
  </primary_outcome>
  <primary_outcome>
    <measure>Change from baseline in youth self-reported anxious symptoms at 3 weeks follow-up</measure>
    <time_frame>3 weeks from baseline (after completing the 3rd weekly training session)</time_frame>
    <description>Youth self-reported anxious symptoms will be assessed by the Youth Self Report questionnaire. The anxious syndrome subscale will be used with a score summed across the 12 items of this subscale. Scores for each item range from 0 to 2, and scores for the subscale range from 0 to 24. Higher scores indicate greater anxious symptoms.</description>
  </primary_outcome>
  <primary_outcome>
    <measure>Change from baseline in youth self-reported anxious symptoms at 6 weeks follow-up</measure>
    <time_frame>6 weeks from baseline (after completing the 6th weekly training session)</time_frame>
    <description>Youth self-reported anxious symptoms will be assessed by the Youth Self Report questionnaire. The anxious syndrome subscale will be used with a score summed across the 12 items of this subscale. Scores for each item range from 0 to 2, and scores for the subscale range from 0 to 24. Higher scores indicate greater anxious symptoms.</description>
  </primary_outcome>
  <secondary_outcome>
    <measure>Change from baseline in response-time-indexed Attentional Bias (AB) at 6 weeks follow-up</measure>
    <time_frame>6 weeks from baseline (after completing the 6th weekly training session)</time_frame>
    <description>This outcome will be assessed by a behavioral dot-probe task.</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Change from baseline in eye-movement-indexed Attentional Bias (AB) at 6 weeks follow-up</measure>
    <time_frame>6 weeks from baseline (after completing the 6th weekly training session)</time_frame>
    <description>This outcome will be assessed by an eye-tracking task.</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Change from baseline in resting-state functional connectivity (rsFC)</measure>
    <time_frame>6 weeks from baseline (after completing the 6th weekly training session)</time_frame>
    <description>rsFC will be assessed by resting-state functional magnetic resonance imaging (fMRI).</description>
  </secondary_outcome>
  <number_of_arms>2</number_of_arms>
  <enrollment type="Anticipated">60</enrollment>
  <condition>Attentional Bias</condition>
  <condition>Anxiety</condition>
  <arm_group>
    <arm_group_label>Attentional Bias Modification (ABM) group</arm_group_label>
    <arm_group_type>Active Comparator</arm_group_type>
    <description>Participants in this arm will participate in a six-session ABM task, one session per week.</description>
  </arm_group>
  <arm_group>
    <arm_group_label>Control group</arm_group_label>
    <arm_group_type>Placebo Comparator</arm_group_type>
    <description>Participants in this arm will participate in a six-session control task, one session per week.</description>
  </arm_group>
  <intervention>
    <intervention_type>Behavioral</intervention_type>
    <intervention_name>Attentional Bias Modification (ABM) task</intervention_name>
    <description>Participants will be presented with a fixation cross (500ms) followed by a pair of identity-matched, angry-neutral faces (1000ms). The pair presentation is replaced by a single arrow-probe (1000ms) in the position of the neural face. Inter-trial intervals (ITI) are 500ms. Participants indicate arrow direction (left or right) by pressing one of two buttons as quickly as possible. By responding to the probe that always replaces the neutral face, participants learn to attend to the non-threat cues and away from threat cues. There are 120 trials of angry-neutral faces in total, and 40 other catch trials with neutral-neutral faces.</description>
    <arm_group_label>Attentional Bias Modification (ABM) group</arm_group_label>
  </intervention>
  <intervention>
    <intervention_type>Behavioral</intervention_type>
    <intervention_name>Control task</intervention_name>
    <description>The control task is identical with the ABM task, except that in the 120 angry-neutral trials, the arrow-probe replaces the angry face and the neutral face with equal probabilities (60 trials each).</description>
    <arm_group_label>Control group</arm_group_label>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  English-speaking 11-13-year-old youth without significant medical, psychological,
             cognitive, or language impairments.

        Exclusion Criteria:

          -  Adolescents with clinically significant anxiety disorders or conditions in conflict
             with MRI scanning (e.g., orthodontics) will be excluded.
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>11 Years</minimum_age>
    <maximum_age>13 Years</maximum_age>
    <healthy_volunteers>Accepts Healthy Volunteers</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Elizabeth P Hayden, Ph.D</last_name>
    <role>Principal Investigator</role>
    <affiliation>Western University</affiliation>
  </overall_official>
  <overall_contact>
    <last_name>Elizabeth P Hayden, Ph.D</last_name>
    <phone>519-661-3686</phone>
    <email>ehayden@uwo.ca</email>
  </overall_contact>
  <location>
    <facility>
      <name>Western University</name>
      <address>
        <city>London</city>
        <state>Ontario</state>
        <zip>N6A 5B7</zip>
        <country>Canada</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Elizabeth Hayden, Ph.D.</last_name>
      <phone>519-661-3686</phone>
      <email>ehayden@uwo.ca</email>
    </contact>
  </location>
  <location_countries>
    <country>Canada</country>
  </location_countries>
  <reference>
    <citation>Sanchez A, Romero N, De Raedt R. Depression-related difficulties disengaging from negative faces are associated with sustained attention to negative feedback during social evaluation and predict stress recovery. PLoS One. 2017 Mar 31;12(3):e0175040. doi: 10.1371/journal.pone.0175040. eCollection 2017.</citation>
    <PMID>28362826</PMID>
  </reference>
  <results_reference>
    <citation>Beard C, Sawyer AT, Hofmann SG. Efficacy of attention bias modification using threat and appetitive stimuli: a meta-analytic review. Behav Ther. 2012 Dec;43(4):724-40. doi: 10.1016/j.beth.2012.01.002. Epub 2012 Jan 18. Review.</citation>
    <PMID>23046776</PMID>
  </results_reference>
  <results_reference>
    <citation>Bar-Haim Y, Lamy D, Pergamin L, Bakermans-Kranenburg MJ, van IJzendoorn MH. Threat-related attentional bias in anxious and nonanxious individuals: a meta-analytic study. Psychol Bull. 2007 Jan;133(1):1-24.</citation>
    <PMID>17201568</PMID>
  </results_reference>
  <results_reference>
    <citation>Liu P, Taber-Thomas BC, Fu X, PÃ©rez-Edgar KE. Biobehavioral Markers of Attention Bias Modification in Temperamental Risk for Anxiety: A Randomized Control Trial. J Am Acad Child Adolesc Psychiatry. 2018 Feb;57(2):103-110. doi: 10.1016/j.jaac.2017.11.016. Epub 2017 Nov 28.</citation>
    <PMID>29413142</PMID>
  </results_reference>
  <verification_date>September 2019</verification_date>
  <study_first_submitted>May 30, 2019</study_first_submitted>
  <study_first_submitted_qc>May 31, 2019</study_first_submitted_qc>
  <study_first_posted type="Actual">June 4, 2019</study_first_posted>
  <last_update_submitted>September 30, 2019</last_update_submitted>
  <last_update_submitted_qc>September 30, 2019</last_update_submitted_qc>
  <last_update_posted type="Actual">October 2, 2019</last_update_posted>
  <responsible_party>
    <responsible_party_type>Principal Investigator</responsible_party_type>
    <investigator_affiliation>Western University, Canada</investigator_affiliation>
    <investigator_full_name>Elizabeth Hayden</investigator_full_name>
    <investigator_title>Professor</investigator_title>
  </responsible_party>
  <keyword>Attentional Bias</keyword>
  <keyword>Anxiety risk</keyword>
  <keyword>Adolescence</keyword>
  <keyword>Eye-tracking</keyword>
  <keyword>Resting-state functional magnetic resonance imaging</keyword>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Anxiety Disorders</mesh_term>
  </condition_browse>
  <patient_data>
    <sharing_ipd>Yes</sharing_ipd>
    <ipd_description>De-identified individual participant data for outcome measures will be made available.</ipd_description>
    <ipd_info_type>Study Protocol</ipd_info_type>
    <ipd_info_type>Statistical Analysis Plan (SAP)</ipd_info_type>
    <ipd_info_type>Informed Consent Form (ICF)</ipd_info_type>
    <ipd_info_type>Analytic Code</ipd_info_type>
    <ipd_time_frame>Data will be available within 6 months of study completion.</ipd_time_frame>
    <ipd_access_criteria>Data access requests will be reviewed by the PI. Requests with the sole purpose of research will be approved. Requestors will be required to sign a data access agreement.</ipd_access_criteria>
  </patient_data>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

